Brodin, Bertha A.
Wennerberg, Krister
Lidbrink, Elisabet
Brosjö, Otte
Potdar, Swapnil
Wilson, Jennifer N.
Ma, Limin
Moens, Lotte N.
Hesla, Asle
Porovic, Edvin
Bernhardsson, Edvin
Papakonstantinou, Antroula
Bauer, Henrik
Tsagkozis, Panagiotis
von Sivers, Karin
Wejde, Johan
Östling, Päivi
Kallioniemi, Olli
Stragliotto, Christina Linder
Funding for this research was provided by:
Barncancerfonden (KP20160042, KP20160042)
Cancerföreningen i Stockholm (151033, 084141)
Kurt and Lillian Sagens Stiftelse Liddy Shriver Sarcoma Initiative
Article History
Received: 22 March 2018
Revised: 26 October 2018
Accepted: 22 November 2018
First Online: 12 February 2019
Competing interests
: The authors declare no competing interests.
: All authors have read the paper and given consent for publication.
: The presented research was conducted with the ethical standards that promote and ensure respect and integrity for all human subjects that participated and justified by the potential benefit to the patient, all in accordance to the Declaration of Helsinki. The collection and use of biopsy material for molecular studies was approved by Central Ethical Review Board in Stockholm (regionala etikprövningsnämnden) No. 2013-1979-31-3. All patients were informed prior to surgery/biopsy and gave consent for using their tumour samples during and after the study.
: All data and material are available upon request. Biopsies and cell cultures are accessible provided ethical approval and sample availability.